Byetta

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0310-6512
  • Package NDC 0310-6512-01
  • Application number NDA021773
  • SPL ID 7333a7dd-9449-4c61-b36d-c5d8d7cc239b
  • SPL set ID 53d03c03-ebf7-418d-88a8-533eabd2ee4f
  • UNII 9P1872D4OL
  • RxCUI 847910
  • RxCUI 847913
  • RxCUI 847915
  • RxCUI 847917

What the source publishes

Labeler
AstraZeneca Pharmaceuticals LP
Active ingredients
exenatide
Form
INJECTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0310-6512_7333a7dd-9449-4c61-b36d-c5d8d7cc239b
{
  "name": "Byetta",
  "splId": "7333a7dd-9449-4c61-b36d-c5d8d7cc239b",
  "labels": [
    {
      "setId": "53d03c03-ebf7-418d-88a8-533eabd2ee4f",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d03c03-ebf7-418d-88a8-533eabd2ee4f",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=53d03c03-ebf7-418d-88a8-533eabd2ee4f"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "AstraZeneca Pharmaceuticals LP",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 CARTRIDGE in 1 CARTON (0310-6512-01)  / 1.2 mL in 1 CARTRIDGE",
      "package_ndc": "0310-6512-01",
      "identifierStatus": "well-formed",
      "marketing_end_date": "20261231",
      "marketing_start_date": "20141210"
    }
  ],
  "productId": "0310-6512_7333a7dd-9449-4c61-b36d-c5d8d7cc239b",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "0310-6512",
  "deaSchedule": null,
  "genericName": "exenatide",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": "20261231",
  "activeIngredients": [
    {
      "name": "EXENATIDE",
      "strength": "250 ug/mL"
    }
  ],
  "applicationNumber": "NDA021773",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20141210",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000178480",
      "M0160181",
      "N0000020058"
    ],
    "unii": [
      "9P1872D4OL"
    ],
    "rxcui": [
      "847910",
      "847913",
      "847915",
      "847917"
    ],
    "spl_set_id": [
      "53d03c03-ebf7-418d-88a8-533eabd2ee4f"
    ],
    "pharm_class_cs": [
      "Glucagon-Like Peptide 1 [CS]"
    ],
    "pharm_class_epc": [
      "GLP-1 Receptor Agonist [EPC]"
    ],
    "pharm_class_moa": [
      "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
    ],
    "manufacturer_name": [
      "AstraZeneca Pharmaceuticals LP"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0310-6512_7333a7dd-9449-4c61-b36d-c5d8d7cc239b"